The Long Journey towards Personalized Targeted Therapy in Poorly Differentiated Thyroid Carcinoma (PDTC): A Case Report and Systematic Review.

Odysseas VioletisPanagiota KonstantakouAriadni Spyroglou Antonios XydakisPanagiotis B KekisSofia TseleniDenise KolomodiManousos KonstadoulakisMastorakos GeorgeMaria TheochariJavier AllerKrystallenia I Alexandraki

Published in: Journal of personalized medicine (2024)

Our case, together with the systematic review, imply that a combination of molecular-targetedtreatments may be safe and effective in patients with RAI-resistantBRAF-mutated advanced PDTC when surgery has failed to control tumor progression.

Keyphrases

systematic review
meta analyses
minimally invasive
poor prognosis
randomized controlled trial
coronary artery bypass
percutaneous coronary intervention